CollPlant Biotechnologies Raising $4.45 Million in U.S. Private Placement

0

0

CollPlant (NASDAQ: CLGN) (the “Company”), a regenerative and aesthetic medicine company, announced it has entered into definitive agreements for up to $4.45 million. The capital raise is by way of a non-brokered private placement with U.S. accredited investors who have many years of deep experience in medical and 3D printing.

This article was first featured at https://ift.tt/2vBWLYX on February 14, 2020 at 07:36AM by

John Jason Fallows

See author's posts